Frequency of Hepatitis B Virus and Hepatitis C Virus Infection in Beta Thalassemia Major Children in Tertiary Care Hospital
DOI:
https://doi.org/10.70749/ijbr.v3i1.490Keywords:
Beta-thalassemia Major, Hepatitis B, Hepatitis C, Blood TransfusionsAbstract
Introduction: The study aimed to determine the frequency of hepatitis B virus and hepatitis C virus infection in children with beta thalassemia major receiving treatment at a tertiary care hospital. Methodology: This descriptive cross-sectional study was conducted over six months, from April 2024 to October 2024, in the Department of Pediatrics at PIMS Hospital, Islamabad. A total of 161 beta-thalassemia major patients, aged 1 to 15 years, were included using non-probability consecutive sampling. Participants with prior HBV or HCV diagnoses, liver disease, or a history of antiviral treatment were excluded. Data on demographics, transfusion history, and infection status were collected. Blood samples were analyzed for HBV and HCV RNA levels using Real-Time PCR. Statistical analysis was performed using SPSS version 26, with infections stratified by age, gender, and transfusion frequency. A p-value ≤0.05 was considered statistically significant. Results: The mean age of participants was 7.98±4.29 years, with an average of 15.95±8.57 transfusions. Males constituted 59.6% of the sample. HBV was detected in 9.9% of patients, and HCV in 31.7%. HBV positivity was significantly associated with age (>10 years: 17%, p=0.036) and number of transfusions (>20 transfusions: 17%, p=0.036). Similarly, HCV positivity dramatically increased with age (>10 years: 83%, p=0.000) and transfusions (>20 transfusions: 83%, p=0.000). Gender differences in infection rates were not statistically significant. Conclusion: Hepatitis B and C infections pose significant risks for beta-thalassemia major patients, with HCV showing a higher prevalence. Older age and increased transfusions significantly elevate infection risk, underscoring the need for enhanced screening protocols and targeted preventive strategies.
Downloads
References
Ali, S., Mumtaz, S., Shakir, H. A., Khan, M., Tahir, H. M., Mumtaz, S., Mughal, T. A., Hassan, A., Kazmi, S. A., Sadia, Irfan, M., & Khan, M. A. (2021). Current status of beta‐thalassemia and its treatment strategies. Molecular Genetics & Genomic Medicine, 9(12). https://doi.org/10.1002/mgg3.1788
Angastiniotis, M., & Lobitz, S. (2019). Thalassemias: An overview. International Journal of Neonatal Screening, 5(1), 16. https://doi.org/10.3390/ijns5010016
Farmakis, D., Porter, J., Taher, A., Domenica Cappellini, M., Angastiniotis, M., & Eleftheriou, A. (2022). 2021 thalassaemia international Federation guidelines for the management of transfusion-dependent thalassemia. HemaSphere, 6(8), e732. https://doi.org/10.1097/hs9.0000000000000732
Pinto, V., & Forni, G. (2020). Management of iron overload in beta-thalassemia patients: Clinical practice update based on case series. International Journal of Molecular Sciences, 21(22), 8771. https://doi.org/10.3390/ijms21228771
Naz, R., Ullah, F., Muhammad, T., Khan, O., Shah, F., Rehman, A. U., & Basir, N. U. (2023). Incidence of hepatitis B due to multiple transfusions in patients of β-thalassemia major. Pakistan Journal of Health Sciences, 86-90. https://doi.org/10.54393/pjhs.v4i02.558
Al-Busafi, S. A., & Alwassief, A. (2024). Global perspectives on the hepatitis B vaccination: Challenges, achievements, and the road to elimination by 2030. Vaccines, 12(3), 288. https://doi.org/10.3390/vaccines12030288
Rizzo, G. E., Cabibbo, G., & Craxì, A. (2022). Hepatitis B virus-associated hepatocellular carcinoma. Viruses, 14(5), 986. https://doi.org/10.3390/v14050986
Mahmood, F., Xu, R., Awan, M. U., Song, Y., Han, Q., Xia, X., Wei, J., Xu, J., Peng, J., & Zhang, J. (2023). HBV vaccines: Advances and development. Vaccines, 11(12), 1862. https://doi.org/10.3390/vaccines11121862
Waheed, U., Saba, N., Wazeer, A., & Ahmed, S. (2021). A systematic review and meta-analysis on the epidemiology of hepatitis B and hepatitis C virus among beta-thalassemia major patients in Pakistan. Journal of Laboratory Physicians, 13(03), 270-276. https://doi.org/10.1055/s-0041-1731110
Chozie, N. A., Satiti, M. A., Sjarif, D. R., Oswari, H., & Ritchie, N. K. (2022). The impact of nucleic acid testing as a blood donor screening method in transfusion-associated hepatitis C among children with bleeding disorders in Indonesia: A single-center experience. Blood Research, 57(2), 129-134. https://doi.org/10.5045/br.2022.2021219
Negro, F. (2019). Natural history of hepatic and extrahepatic hepatitis C virus diseases and impact of interferon-free HCV therapy. Cold Spring Harbor Perspectives in Medicine, 10(4), a036921. https://doi.org/10.1101/cshperspect.a036921
Brzdęk, M., Zarębska-Michaluk, D., Invernizzi, F., Cilla, M., Dobrowolska, K., & Flisiak, R. (2023). Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C. World Journal of Gastroenterology, 29(6), 949-966. https://doi.org/10.3748/wjg.v29.i6.949
Origa, R. (2023). Hepatitis C and thalassemia: A story with (Almost) a happy ending. Pathogens, 12(5), 683. https://doi.org/10.3390/pathogens12050683
Nadir, R., Anjum, A., & Ijaz, S. F.(2020). Frequency of hepatitis B and C in Beta thalassemia major with multiple blood transfusions. Pak J Med Health Sci, 14(4), 764-5. https://pjmhsonline.com/2020/oct_dec/764.pdf
Iqbal, B. M. M., Hassan, S., & Aziz, S. (2010). FREQUENCY OF HEPATITIS B AND HEPATITIS C IN MULTI-TRANSFUSED BETA THALASSEMIA MAJOR PATIENTS: Hepatitis B and Hepatitis C in beta Thalassemia Major. Pakistan Armed Forces Medical Journal, 60(2), 285-88. https://pafmj.org/PAFMJ/article/view/873
Akhtar, S., Nasir, J. A., & Hinde, A. (2020). The prevalence of hepatitis C virus infection in β-thalassemia patients in Pakistan: A systematic review and meta-analysis. BMC Public Health, 20(1). https://doi.org/10.1186/s12889-020-8414-5
Mirzaei, G., Shamsasenjan, K., Jafari, B., Bagherizadeh, Y., Sadafzadeh, A., Bannazadeh-Baghi, H., Sadeghi-Deylamdeh, Z., & Jafari-Sales, A. (2021). Prevalence of HBV and HCV infection in beta-thalassemia major patients of Tabriz city, Iran. New Microbes and New Infections, 43, 100912. https://doi.org/10.1016/j.nmni.2021.100912
Nadir, R., Anjum, A., & Ijaz, S. F.(2020). Frequency of hepatitis B and C in Beta thalassemia major with multiple blood transfusions. Pak J Med Health Sci, 14(4), 764-5. https://pjmhsonline.com/2020/oct_dec/764.pdf
Khalil, S., Khan, H. S., & Akhtar, P. (2016). Status of hepatitis B and C in beta thalassemia major patients. Journal of Islamabad Medical & Dental College (JIMDC), 5(2), 71-73. https://jimdc.org.pk/jimdc/Volumes/5-2/Status%20of%20Hepatitis%20B%20and%20C%20in%20Thalassemic%20Patients.pdf
Kousar, T., Qureshi, R., Lohano, B. C., Das, C., & Hotwani, S. (2021). Frequency of hepatitis C virus and hepatitis B virus among children undergoing multiple blood transfusions. Pakistan Journal of Medical and Health Sciences, 15(10), 3384-3386. https://doi.org/10.53350/pjmhs2115103384
Ullah , A., Shinwari, A. ., Ullah, S. ., Ahmad, A. ., Khan, S. ., Zeeshan, M. ., Ullah, N. ., Rabnawaz, M. ., & Muhammad, W. (2023). PREVALENCE OF HEPATITIS B AND HEPATITIS C VIRUSES AND ITS CORRELATION WITH BETA THALASSEMIA MAJOR PATIENTS IN PESHAWAR, KHYBER PAKHTUNKHWA . Rehman Journal of Health Sciences, 5(2), 177–183. https://doi.org/10.52442/rjhs.v5i2.389
Bhuyan, G, S., Hossain, M. A., Sarker, S. K, Islam, M. S, Arafat, Y., Sarker S, et al. (2021). Frequency of Hepatitis B, C and HIV infections among transfusion-dependent beta thalassemia patients in Dhaka. Infect Dis Rep, 13(1), 89-95. https://doi.org/10.3390/idr13010011
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
